122 related articles for article (PubMed ID: 16708300)
1. Immunohistochemical demonstration of c-Kit protooncogene product in gallbladder cancer.
Tanaka S; Tanaka H; Yamamoto T; Shuto T; Takemura S; Hai S; Sakabe K; Uenishi T; Hirohashi K; Kubo S
J Hepatobiliary Pancreat Surg; 2006; 13(3):228-34. PubMed ID: 16708300
[TBL] [Abstract][Full Text] [Related]
2. Analysis of KIT (CD117) expression in gallbladder carcinomas by tissue microarray.
Langner C; Lemmerer M; Kornprat P
Eur J Surg Oncol; 2004 Oct; 30(8):847-50. PubMed ID: 15336730
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study.
Brustmann H
Gynecol Oncol; 2005 Sep; 98(3):396-402. PubMed ID: 16005054
[TBL] [Abstract][Full Text] [Related]
4. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
Massard C; Voigt JJ; Laplanche A; Culine S; Lortholary A; Bugat R; Theodore C; Priou F; Kaminsky MC; Lesimple T; Pivot X; Coudert B; Douillard JY; Merrouche Y; Fizazi K
Br J Cancer; 2007 Oct; 97(7):857-61. PubMed ID: 17876336
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological significance of expression of c-kit protein in neuroendocrine lung carcinoma].
Zhao P; Hou N; Shao Y; Li XH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1526-9. PubMed ID: 16179109
[TBL] [Abstract][Full Text] [Related]
7. Tumor angiogenesis in gallbladder carcinoma.
Sugawara Y; Makuuchi M; Harihara Y; Noie T; Inoue K; Kubota K; Takayama T
Hepatogastroenterology; 1999; 46(27):1682-6. PubMed ID: 10430321
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of microvessel density, CD44 (standard form), p53 protein and c-erbB2 in gallbladder carcinoma.
Kalekou H; Miliaras D
J Gastroenterol Hepatol; 2004 Jul; 19(7):812-8. PubMed ID: 15209630
[TBL] [Abstract][Full Text] [Related]
9. Expression of HER2 and C-KIT in nasopharyngeal carcinoma: implications for a new therapeutic approach.
Bar-Sela G; Kuten A; Ben-Eliezer S; Gov-Ari E; Ben-Izhak O
Mod Pathol; 2003 Oct; 16(10):1035-40. PubMed ID: 14559987
[TBL] [Abstract][Full Text] [Related]
10. [Expression of c-kit in North African nasopharyngeal carcinomas: correlation with age and LMP1].
Charfi S; Khabir A; Ayadi L; Mseddi M; Makni H; Gorbel A; Daoud J; Frikha M; Jlidi R; Busson P; Boudawara TS
Cancer Radiother; 2007 Sep; 11(5):247-51. PubMed ID: 17689127
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
Kara B; Doran F; Kara IO; Akkiz H; Sandikci M
Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
[TBL] [Abstract][Full Text] [Related]
12. Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer.
Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS
J Hepatobiliary Pancreat Surg; 2009; 16(3):315-21. PubMed ID: 19259612
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma.
Kim HS; Kim GY; Lim SJ; Park YK; Kim YW
Hum Pathol; 2010 Nov; 41(11):1609-16. PubMed ID: 20688353
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer.
Kim WB; Han HJ; Lee HJ; Park SS; Song TJ; Kim HK; Suh SO; Kim YC; Choi SY
Ann Surg Oncol; 2009 Jan; 16(1):23-34. PubMed ID: 18979138
[TBL] [Abstract][Full Text] [Related]
15. Primary gallbladder sarcoma: a clinicopathologic study of 15 cases, heterogeneous sarcomas with poor outcome, except pediatric botryoid rhabdomyosarcoma.
Al-Daraji WI; Makhlouf HR; Miettinen M; Montgomery EA; Goodman ZD; Marwaha JS; Fanburg-Smith JC
Am J Surg Pathol; 2009 Jun; 33(6):826-34. PubMed ID: 19194282
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of KIT expression in small cell lung cancer.
López-Martin A; Ballestín C; Garcia-Carbonero R; Castaño A; Lopez-Ríos F; López-Encuentra A; Sánchez-Cespedes M; Castellano D; Bartolomé A; Cortés-Funes H; Paz-Ares L
Lung Cancer; 2007 Jun; 56(3):405-13. PubMed ID: 17420067
[TBL] [Abstract][Full Text] [Related]
17. Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapy.
Fine RL; Shah SS; Moulton TA; Yu IR; Fogelman DR; Richardson M; Burris HA; Samuels BL; Assanasen C; Gorroochurn P; Hibshoosh H; Orjuela M; Garvin J; Goldman FD; Dubovsky D; Walterhouse D; Halligan G
Cancer Chemother Pharmacol; 2007 Mar; 59(4):429-37. PubMed ID: 16896931
[TBL] [Abstract][Full Text] [Related]
18. Outcome of radical surgery for stage IV gallbladder carcinoma.
Chijiiwa K; Kai M; Nagano M; Hiyoshi M; Ohuchida J; Kondo K
J Hepatobiliary Pancreat Surg; 2007; 14(4):345-50. PubMed ID: 17653631
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-kit in uterine carcinosarcoma.
Menczer J; Kravtsov V; Levy T; Berger E; Glezerman M; Avinoach I
Gynecol Oncol; 2005 Jan; 96(1):210-5. PubMed ID: 15589603
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
